secwatch / observer

8-K filed June 2, 2026, 7:05 AM ET ticker RZLT CIK 0001509261

other material confidence high sentiment positive materiality 0.75

Rezolute reports positive interim Phase 3 upLIFT data: 6 of 8 patients met primary endpoint

Rezolute, Inc.

8 patients enrolled (50% of planned 16); 6 responders with ≥50% reduction in IV glucose, all 6 achieved complete discontinuation.
One patient withdrew due to cancer progression (Stage 4 colon cancer) counted as non-responder; one patient recently enrolled and dosing.
No drug-related adverse events; all completing pivotal phase entered open-label extension, cumulative treatment up to 6 months.
Topline results for fully enrolled study expected in second half of 2026.
Data supports ersodetug as potential universal treatment for refractory hypoglycemia from congenital and acquired hyperinsulinism.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-069206
form_type: 8-K
ticker: RZLT
cik: 0001509261
company_name: Rezolute, Inc.
filed_at: 2026-06-02T11:05:59+00:00
discovered_at: 2026-06-02T11:10:00.234617+00:00
generated_at: 2026-06-02T11:10:49.217306+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-069206
json_url: https://secwatch.observer/filing/0001104659-26-069206.json
markdown_url: https://secwatch.observer/filing/0001104659-26-069206.md
text_url: https://secwatch.observer/filing/0001104659-26-069206.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1509261/000110465926069206/0001104659-26-069206-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1509261/000110465926069206/tm2616579d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

USAR

USA Rare Earth selects South Carolina for $1.2B magnet facility; 490 jobs, 6,400 tpa capacity

USA Rare Earth, Inc. June 2, 2026, 9:14 AM ET other_material Items 1.01, 2.03, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OLOX

Olenox reports May 2026 Bitcoin production of 18.6 BTC; first update after CS Digital acquisition

OLENOX INDUSTRIES INC. June 2, 2026, 8:30 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CELC

Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial

Celcuity Inc. June 2, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SHAK

Shake Shack cuts Q2 revenue guidance to $415-420M, same-shack sales to 2.5-3.0%

Shake Shack Inc. June 2, 2026, 8:06 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

UIS

Unisys issues upwardly revised FY2026 revenue guidance at Investor Day, no specific figures in filing

UNISYS CORP June 2, 2026, 8:04 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRCC

BRCC regains NYSE minimum share price compliance; reverse split approved but not needed

BRC Inc. June 2, 2026, 6:18 AM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TRTX

TRTX posts 1Q26 distributable earnings $0.25/sh, book value $11.06, loan portfolio $4.3B

TPG RE Finance Trust, Inc. June 1, 2026, 5:23 PM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-26-069206

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.